FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2051897629> ?p ?o ?g. }

• W2051897629 endingPage "243" @default.
• W2051897629 startingPage "237" @default.
• W2051897629 abstract "Fluconazole (2-(2,4-difluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)-2-propanol) is a triazole antifungal agent that has been available since 1990. Fluconazole is a broad-spectrum triazole antifungal agent that has emerged as a suitable alternative to amphotericin B in the treatment of a wide variety of superficial and systemic fungal infections.1 Triazole drugs act by inhibiting the enzyme 14-α-demethylase, which belongs to the microsomal CYP system; triazoles also act by blocking the biosynthesis of ergosterol, resulting in the accumulation of 14-α-methyl sterols and producing a fungistatic action. In general, fluconazole is well tolerated, with side effects including nausea, headache, skin rash, vomiting, abdominal pain, and diarrhea occurring during long-term therapy.2Excellent bioavailability has been reported after oral dosing, and a linear pharmacokinetics has been demonstrated at a dose of 200–800 mg daily. The elimination half-life of fluconazole ranges from 27 to 37 hours, the apparent volume of distribution ranges from 0.5 to 0.7 L/kg, and approximately 80% of unchanged drug is excreted in the urine.3–6Fluconazole is now used prophylactically in the management of various immune-compromised patient subsets1. High morbidity and mortality in patients with severe thermal injury were associated with fungal sepsis; thus, a study of the efficacy of this drug to prevent fungal sepsis in burn patients is necessary. It is well-known that patients with thermal injuries show many changes in the pharmacokinetics of several drugs, but data on the clinical efficacy of fluconazole related to its kinetics are very limited.7,8 Since changes in the pharmacokinetics of fluconazole are still unknown, it is imperative to investigate burn patients’ drug levels with a controlled clinical protocol.Analytical methods using microbiological, spectrophotometric, and chromatographic techniques have all been shown to determine fluconazole in biological samples. High-performance liquid chromatography (HPLC) is preferred due to its selectivity and the specificity of the assay. Methods for the determination of fluconazole in biological samples by HPLC-UV have been described previously.9–16 The objective of the present study was to develop a simple analytical method to determine fluconazole for plasma drug monitoring in patients with extensive thermal injury. An additional focus is its application to future pharmacokinetic studies. The method was validated as per FDA guidelines.17" @default.
• W2051897629 created "2016-06-24" @default.
• W2051897629 creator A5013379393 @default.
• W2051897629 creator A5029808553 @default.
• W2051897629 creator A5030437380 @default.
• W2051897629 creator A5056948753 @default.
• W2051897629 creator A5075547178 @default.
• W2051897629 date "2010-02-01" @default.
• W2051897629 modified "2023-09-30" @default.
• W2051897629 title "Fluconazole plasma concentration measurement by liquid chromatography for drug monitoring of burn patients" @default.
• W2051897629 cites W1555208341 @default.
• W2051897629 cites W1965591649 @default.
• W2051897629 cites W1986293290 @default.
• W2051897629 cites W2002205662 @default.
• W2051897629 cites W2018445998 @default.
• W2051897629 cites W2050980819 @default.
• W2051897629 cites W2064712711 @default.
• W2051897629 cites W2069326210 @default.
• W2051897629 cites W2072984719 @default.
• W2051897629 cites W2089128513 @default.
• W2051897629 cites W2094190215 @default.
• W2051897629 cites W2099567487 @default.
• W2051897629 cites W2107333376 @default.
• W2051897629 cites W2111240123 @default.
• W2051897629 cites W2113939460 @default.
• W2051897629 cites W2114396121 @default.
• W2051897629 cites W2121652735 @default.
• W2051897629 cites W2122917895 @default.
• W2051897629 cites W2141751458 @default.
• W2051897629 cites W2143359646 @default.
• W2051897629 cites W2145981463 @default.
• W2051897629 cites W2149925685 @default.
• W2051897629 cites W2160288749 @default.
• W2051897629 cites W2332168013 @default.
• W2051897629 cites W2400892140 @default.
• W2051897629 doi "https://doi.org/10.1590/s1807-59322010000200017" @default.
• W2051897629 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2827712" @default.
• W2051897629 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20186309" @default.
• W2051897629 hasPublicationYear "2010" @default.
• W2051897629 type Work @default.
• W2051897629 sameAs 2051897629 @default.
• W2051897629 citedByCount "18" @default.
• W2051897629 countsByYear W20518976292012 @default.
• W2051897629 countsByYear W20518976292013 @default.
• W2051897629 countsByYear W20518976292015 @default.
• W2051897629 countsByYear W20518976292017 @default.
• W2051897629 countsByYear W20518976292018 @default.
• W2051897629 countsByYear W20518976292020 @default.
• W2051897629 countsByYear W20518976292021 @default.
• W2051897629 countsByYear W20518976292022 @default.
• W2051897629 crossrefType "journal-article" @default.
• W2051897629 hasAuthorship W2051897629A5013379393 @default.
• W2051897629 hasAuthorship W2051897629A5029808553 @default.
• W2051897629 hasAuthorship W2051897629A5030437380 @default.
• W2051897629 hasAuthorship W2051897629A5056948753 @default.
• W2051897629 hasAuthorship W2051897629A5075547178 @default.
• W2051897629 hasBestOaLocation W20518976291 @default.
• W2051897629 hasConcept C16005928 @default.
• W2051897629 hasConcept C185592680 @default.
• W2051897629 hasConcept C2779548794 @default.
• W2051897629 hasConcept C2780035454 @default.
• W2051897629 hasConcept C2780272996 @default.
• W2051897629 hasConcept C2780651595 @default.
• W2051897629 hasConcept C43617362 @default.
• W2051897629 hasConcept C71924100 @default.
• W2051897629 hasConcept C98274493 @default.
• W2051897629 hasConceptScore W2051897629C16005928 @default.
• W2051897629 hasConceptScore W2051897629C185592680 @default.
• W2051897629 hasConceptScore W2051897629C2779548794 @default.
• W2051897629 hasConceptScore W2051897629C2780035454 @default.
• W2051897629 hasConceptScore W2051897629C2780272996 @default.
• W2051897629 hasConceptScore W2051897629C2780651595 @default.
• W2051897629 hasConceptScore W2051897629C43617362 @default.
• W2051897629 hasConceptScore W2051897629C71924100 @default.
• W2051897629 hasConceptScore W2051897629C98274493 @default.
• W2051897629 hasIssue "2" @default.
• W2051897629 hasLocation W20518976291 @default.
• W2051897629 hasLocation W20518976292 @default.
• W2051897629 hasLocation W20518976293 @default.
• W2051897629 hasLocation W20518976294 @default.
• W2051897629 hasLocation W20518976295 @default.
• W2051897629 hasLocation W20518976296 @default.
• W2051897629 hasOpenAccess W2051897629 @default.
• W2051897629 hasPrimaryLocation W20518976291 @default.
• W2051897629 hasRelatedWork W1501468464 @default.
• W2051897629 hasRelatedWork W1978232308 @default.
• W2051897629 hasRelatedWork W2037989399 @default.
• W2051897629 hasRelatedWork W2353996886 @default.
• W2051897629 hasRelatedWork W2461387776 @default.
• W2051897629 hasRelatedWork W2580937385 @default.
• W2051897629 hasRelatedWork W2748952813 @default.
• W2051897629 hasRelatedWork W2899084033 @default.
• W2051897629 hasRelatedWork W4241497131 @default.
• W2051897629 hasRelatedWork W3021183803 @default.
• W2051897629 hasVolume "65" @default.
• W2051897629 isParatext "false" @default.
• W2051897629 isRetracted "false" @default.
• W2051897629 magId "2051897629" @default.

• next